Immco Diagnostics, Inc. · Class II · Cleared Jun 19, 2017
| K-number | K162788 |
| Device name | ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enhanced B2GP1 IgA/IgG/IgM Antibody ELISA |
| Applicant | Immco Diagnostics, Inc. |
| Product code | MSV |
| Device class | Class II |
| Decision date | Jun 19, 2017 |
| Decision | Substantially Equivalent |
| Regulation | 866.5660 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov